Author: oncologs.com

It’s summer and time to enjoy the sunshine. But it’s also important to do so safely. Skin cancer is the most common form of cancer in the United States—and it’s most commonly caused by sun exposure. Research has shown that skin self-awareness and regular skin

Drugs developed to combat HIV and AIDS are being trialled for the first time in patients with multiple brain tumours. Credit: University of Plymouth Drugs developed to combat HIV and AIDS are being trialled for the first time in patients with multiple brain tumours. Scientists

Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide. The complexity of its pathogenesis, involving genetic mutations, dysregulated signaling pathways, and compromised immune surveillance, presents significant challenges for effective treatment. This review provides a comprehensive overview of the key signaling pathways implicated in

“[…] PHA is a rare yet aggressive mesenchymal tumor of the liver, which requires a multi-disciplinary approach to achieve the best patient outcomes.” Credit: 2024 Guzik and Mangla. “[…] PHA is a rare yet aggressive mesenchymal tumor of the liver, which requires a multi-disciplinary approach

HOUSTON ― Researchers at The University of Texas MD Anderson Cancer Center have demonstrated that therapeutically restoring ‘youthful’ levels of a specific subunit of the telomerase enzyme can significantly reduce the signs and symptoms of aging in preclinical models. If these findings are confirmed in clinical

Our bone marrow—the fatty, jelly-like substance inside our bones—is an unseen powerhouse quietly producing 500 billion new blood cells every day. That process is driven by hematopoietic stem cells that generate all of the various types of blood cells in our bodies and regenerating themselves

Researchers from the University of Helsinki and HUS investigated the effects of recurring mutations in the KLHL6 gene in diffuse large B-cell lymphoma, the most common cancer of the lymphatic system. Credit: Leo Meriranta / University of Helsinki Researchers from the University of Helsinki and

A new paper from an interdisciplinary team at MUSC Hollings Cancer Center describes how the bacteria Porphyromonas gingivalis interferes with chemotherapy-induced mitophagy, allowing oral cancer tumors to become resistant to the drug’s effects.   Credit: MUSC A new paper from an interdisciplinary team at MUSC Hollings

Swedish researchers have surveyed all people under the age of 25 who have had cancer since 1958. The study, led by researchers at Linköping University and Region Östergötland, shows that cancer survivors are at greater risk for cardiovascular diseases, other cancers and other diagnoses later

Philadelphia, June 17, 2024 – Early diagnosis of hepatocellular carcinoma (HCC)—one of the most fatal malignancies—is crucial to improve patient survival. In a breakthrough study investigators report on the development of a serum fusion-gene machine-learning model. This important screening tool may increase the five-year survival